Clinical Trials Browser

INDUSTRY × trastuzumab duocarmazine × Tumor-Agnostic × Clear all

NCT02277717 2023-08-14

First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients

Phase 1 Completed

Neoplasm Metastasis, Neoplasms